Literature DB >> 21417507

Using Facebook to increase spontaneous reporting of adverse drug reactions.

Marinela Z Knezevic, Ivana C Bivolarevic, Tanja S Peric, Slobodan M Jankovic.   

Abstract

Mesh:

Year:  2011        PMID: 21417507     DOI: 10.2165/11590110-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  6 in total

1.  Stimulating spontaneous reporting of adverse drug reactions by a patient : directed incentive.

Authors:  Slobodan Jankovic
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Practicing medicine in the age of Facebook.

Authors:  Sachin H Jain
Journal:  N Engl J Med       Date:  2009-08-13       Impact factor: 91.245

3.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

4.  Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook.

Authors:  Jeremy A Greene; Niteesh K Choudhry; Elaine Kilabuk; William H Shrank
Journal:  J Gen Intern Med       Date:  2010-10-13       Impact factor: 5.128

5.  Improving reporting of adverse drug reactions: Systematic review.

Authors:  Mariam Molokhia; Shivani Tanna; Derek Bell
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

6.  Adverse drug reaction reporting by patients in the Netherlands: three years of experience.

Authors:  Joyce de Langen; Florence van Hunsel; Anneke Passier; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

  6 in total
  15 in total

Review 1.  Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors:  Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Social media and networks in pharmacovigilance: boon or bane?

Authors:  I Ralph Edwards; Marie Lindquist
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

3.  Pharmacovigilance for a revolving world: prospects of patient-generated data on the internet.

Authors:  G Niklas Norén
Journal:  Drug Saf       Date:  2014-10       Impact factor: 5.606

4.  A framework for assessing the economic value of pharmacovigilance in low- and middle-income countries.

Authors:  Joseph B Babigumira; Andy Stergachis; Hye Lyn Choi; Alexander Dodoo; Jude Nwokike; Louis P Garrison
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606

5.  Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Tehreem F Butt; Anthony R Cox; Jan R Oyebode; Robin E Ferner
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

6.  Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting.

Authors:  François Montastruc; Haleh Bagheri; Isabelle Lacroix; Christine Damase-Michel; Leila Chebane; Vanessa Rousseau; Emilie Jouanjus; Maryse Lapeyre-Mestre; Geneviève Durrieu; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

Review 7.  Systematic review on the prevalence, frequency and comparative value of adverse events data in social media.

Authors:  Su Golder; Gill Norman; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2015-09-16       Impact factor: 4.335

Review 8.  Social media and pharmacovigilance: A review of the opportunities and challenges.

Authors:  Richard Sloane; Orod Osanlou; David Lewis; Danushka Bollegala; Simon Maskell; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2015-09-02       Impact factor: 4.335

9.  Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization.

Authors:  Andreas Vilhelmsson
Journal:  Front Public Health       Date:  2015-09-01

10.  Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies.

Authors:  Preciosa M Coloma; Benedikt Becker; Miriam C J M Sturkenboom; Erik M van Mulligen; Jan A Kors
Journal:  Drug Saf       Date:  2015-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.